Welcome to BioMarket Group!

    • The product Seasonal Influenza Vaccines Market Forecast has been added to comparison list.

Seasonal Influenza Vaccines Market Forecast

Additional Information

Published Date Aug 6, 2009
Special Offer No
Pages #N/A
PDF Fact Sheet View Fact Sheet for the report Seasonal Influenza Vaccines Market Forecast in PDF format.
Published on Date No
Format Interactive Model
Publisher Datamonitor
Product Line No
Full Title No

Availability: In stock

$15,200.00

Quick Overview

Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals.
Request free sample pages from Seasonal Influenza Vaccines Market Forecast

Introduction

Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges.

Reasons to Purchase

*Review the clinical and commercial factors driving new product decisions in influenza vaccines and the strategies of key players in the market

*Size the market with patient-based scenario forecasts of the seasonal vaccines market and a thorough analysis of the vaccine and antiviral pipeline

*Understand concerns, unmet needs and future opportunities in influenza prevention and therapy

Request free sample pages from Seasonal Influenza Vaccines Market Forecast

Other selected research from the 'Markets' category:


Clinical Laboratory Testing Volume 1: Reagents and Instruments
This study concentrates on the clinical laboratory instrumentation industry market segment and the companion reagents sector in the U.S. and around the world. Learn More


Brazil Biofuel Market Outlook (2007-2010)
This report provides research and objective analysis of Brazilian biofuel industry. This report helps clients… Learn More

Other selected research from the 'Vaccines' category:


Commercial Insight: Vaccines - Reaching Adulthood
The vaccine sector has historically been dominated by five key companies, which derived value from high volume sales or relatively cheap commodity vaccine products. However, recent years have seen the introduction of higher-value offerings, such as Wyeth`s Prevnar, and the involvement of a greater number of smaller vaccine players, changing the dynamics of this sector. Learn More


Pipeline and Commercial Insight: Pediatric & Adolescent Vaccines
The pediatric and adolescent vaccines market encompasses many different classes. DTP and MMR combinations continue to form the mainstay of childhood immunization; however, their growth potential is limited. The key opportunities lie in novel, innovative additions to established schedules, particularly pneumococcal (Prevnar), conjugated meningococcal (Menactra) and HPV (Gardasil) vaccines. Learn More